From Today's 8-K Company Believes All Issues Ar
Post# of 148150
Company Believes All Issues Are Addressable and it Will Be Able to Continue BLA Resubmission CMC and Non-Clinical Sections Will Be Fully Resubmitted as Early as September 2021."
https://www.cytodyn.com/investors/sec-filings...248005.pdf
CytoDyn Inc (CYDY) Stock Research Links
Le-Ron-Li-Mab, and they have not.